MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Proceeds from the sale ofequipment$156K Net cash provided by(used in) investing...$64K Canceled cashflow$92K Net increase(decrease) in cash, cash...-$22,997K Canceled cashflow$64K Accounts receivable-$12,584K Stock-based compensationexpense$2,102K Accounts payable$1,727K Interest related to saleof future revenues$1,072K Right-of-use assets-$709K Depreciation$483K Prepaid expenses andother current assets-$248K Other non-cash items-$111K Other non-currentliabilities$52K Purchases of property andequipment$92K Net cash used inoperating activities-$23,061K Canceled cashflow$19,088K Net loss-$24,982K Accrued expenses-$11,362K Accrued interest on saleof future revenues-$5,000K Operating leaseliabilities-$805K
Cash Flow

Editas Medicine, Inc. (EDIT)

Editas Medicine, Inc. (EDIT)

source: myfinsight.com